FDA Inspection 1311632 — Reliance Life Sciences Private Limited
The FDA completed an inspection of Reliance Life Sciences Private Limited on February 27, 2026 in Navi Mumbai. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 27, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Navi Mumbai (India)